Results 201 to 210 of about 19,163 (327)

Risk of Falls Associated with Sedative-Hypnotics in Polymedicated Older Patients

open access: gold, 2023
Montero Balosa   +9 more
openalex   +1 more source

Driving performance in the morning after bedtime vornorexant administration: A randomized clinical trial using a driving simulator

open access: yesPsychiatry and Clinical Neurosciences, EarlyView.
Aim Sedative hypnotics can impair driving performance to a degree comparable to blood alcohol concentrations of 0.05%–0.08%. This study aimed to evaluate the residual effect of vornorexant, a novel orexin receptor antagonist, on next morning driving performance relative to a predefined clinically meaningful threshold.
Yusuke Miyazaki   +5 more
wiley   +1 more source

Psychotropic Medication Exposure via Breast Milk: A Population‐Based Descriptive Study in Denmark

open access: yesPaediatric and Perinatal Epidemiology, EarlyView.
ABSTRACT Background There is limited data on the extent of psychotropic medication exposure through breast milk in infants. This information is essential for identifying research gaps and informing clinical practice. Objectives To examine the prevalence and trend of psychotropic medication exposure among exclusively breastfed infants.
Xiaoqin Liu   +12 more
wiley   +1 more source

Sleep medication and athletic performance – the evidence for practitioners and future research directions.

open access: yesFrontiers in Physiology, 2016
Lee eTaylor   +4 more
doaj   +1 more source

The role of agomelatine in appetite regulation and body weight in rats

open access: yesExperimental Physiology, EarlyView.
Abstract The hypothalamic nuclei play a central role in the synthesis of anorexigenic and orexigenic neuropeptides, which are regulated by peripheral hormones, like leptin and ghrelin. Melatonergic receptors (MT1/MT2) are prominently expressed in the arcuate nucleus of the hypothalamus – an essential hub for appetite control – and in peripheral ...
Engin Korkmaz   +3 more
wiley   +1 more source

Factors associated with treatment failure after discharge in inpatients with schizophrenia spectrum disorders: A retrospective observational study

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim Schizophrenia spectrum disorders are among the most serious mental illnesses that cause social dysfunction. Patients with schizophrenia spectrum disorders are prone to recurrence, and those who require hospitalization are at a high risk; hence, preventing treatment failure after discharge is essential.
Yoshitaka Saito   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy